Details
Stereochemistry | ACHIRAL |
Molecular Formula | C24H28N2O3 |
Molecular Weight | 392.4907 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)C1=CC=C(C(O)=C1)C2=CC3(CCNCC3)OC4=C2C=CC=C4
InChI
InChIKey=ALGHKWSXJUQNJJ-UHFFFAOYSA-N
InChI=1S/C24H28N2O3/c1-3-26(4-2)23(28)17-9-10-18(21(27)15-17)20-16-24(11-13-25-14-12-24)29-22-8-6-5-7-19(20)22/h5-10,15-16,25,27H,3-4,11-14H2,1-2H3
Molecular Formula | C24H28N2O3 |
Molecular Weight | 392.4907 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Adolor Corporation and Pfizer were developing an orally available and selective opioid delta (δ) receptor agonist, ADL 5747 (also known as PF 04856881), for the treatment of pain. ADL-5747 showed efficient pain-reducing properties in the two preclinical models of chronic pain. Their effects were mediated by δ-opioid receptors, with a main contribution of receptors expressed on peripheral Nav1.8-positive neurons. ADL-5747 had been in phase II clinical trials for the treatment of pain. However, this studies on this drug candidate were discontinued in 2010.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01058642
Postherpetic Neuralgia: ADL-5747 150 milligrams (mg) administered orally as 1 ADL5747 150-mg capsule and 1 placebo capsule twice daily (BID) for 14 days during 1 of 2 Treatment Periods.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:02:22 GMT 2023
by
admin
on
Sat Dec 16 08:02:22 GMT 2023
|
Record UNII |
BRJ718SA03
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
850176-30-6
Created by
admin on Sat Dec 16 08:02:22 GMT 2023 , Edited by admin on Sat Dec 16 08:02:22 GMT 2023
|
PRIMARY | |||
|
BRJ718SA03
Created by
admin on Sat Dec 16 08:02:22 GMT 2023 , Edited by admin on Sat Dec 16 08:02:22 GMT 2023
|
PRIMARY | |||
|
11200189
Created by
admin on Sat Dec 16 08:02:22 GMT 2023 , Edited by admin on Sat Dec 16 08:02:22 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |